I Was Thirteen When They Put Me on Estrogen - Jonni Skinner (#39)
Jonni Skinner was thirteen years old when a US gender clinic placed him on cross-sex hormones. His account — fabricated diagnoses, falsified records, coercion and lasting physical harm — arrives as European nations reckon with the same model of care they imported. Sweden and Finland have already restricted paediatric gender medicine; the Netherlands is reviewing the protocol it pioneered; France and Germany face mounting pressure. Jonni's testimony is a warning from inside a system Europe adopted wholesale and is only now beginning to question.
Jonni Skinner grew up in rural Michigan, the child of a religious family, diagnosed with high-functioning autism at four. As a feminine boy experiencing same-sex attraction, puberty brought severe body dysmorphia and profound psychological distress. When his mother sought professional help, she turned to the gender clinic at the University of Michigan. What followed, as Jonni describes it to hosts Stella O'Malley, Mia Hughes and Dr Bret Alderman, was not treatment. It was a sequence of institutional failures that left him with permanent physical and psychological damage. At thirteen, Jonni was placed on cross-sex hormones after what he now understands to have been a fabricated endocrine diagnosis. A year later, a misdiagnosis of tall stature justified higher doses, ostensibly to limit his height. Clinicians sent him to sex shops for so-called treatment supplies. When his mother hesitated, the same practitioners threatened to have Jonni removed from her care. His medical records, he says, were falsified. He spent eight years living under a transgender identity before detransitioning and speaking publicly about what was done to him. The episode is harrowing and specific, but its relevance extends far beyond Michigan. The model of care Jonni encountered drew directly from the Dutch Protocol developed at Amsterdam's VU Medical Centre in the 1990s — the same framework adopted by gender clinics across Sweden, Finland, Germany, France and the United Kingdom. European practitioners did not simply borrow procedures; they imported an ideological framework that prioritised affirmation over differential diagnosis and speed of access over clinical caution. Several northern European countries have since reversed course. Sweden restricted hormonal treatment for minors in 2022. Finland followed. Denmark and Norway commissioned reviews. The Cass Review in the United Kingdom concluded that the evidence base for paediatric gender medicine was remarkably thin. Even the Netherlands, the protocol's birthplace, is now examining its own practices. Yet in France, Germany, Belgium and at EU institutional level, policy has lagged behind this clinical recalibration, and gender clinics continue to operate under frameworks the countries that pioneered them have now abandoned. Jonni Skinner is one of a growing number of detransitioners whose first-person testimony is reshaping the conversation in ways that peer-reviewed papers sometimes cannot. His story is not a general argument against transgender identities; it is an account of what happens when medical institutions abandon the safeguards that protect the most vulnerable. Autistic adolescents, same-sex attracted teenagers, children from difficult home environments — the profiles that appear disproportionately in gender clinic populations — are precisely the patients who require the most careful, unhurried clinical thinking. For European listeners — clinicians, parents, policymakers — this episode is an inventory of institutional failure. Coercion, falsified records, inappropriate contact, threats against a family seeking help: these are not uniquely American pathologies. They are the potential endpoint of any system that prioritises ideological consistency over clinical accountability. The question for Europe is not whether something like this could happen within its own health systems. It is what structures exist to ensure that it does not.
